Cancer treatment and survivorship statistics, 2022

🤖 Plain-English Summary

The number of cancer survivors continues to increase in the United States due to the growth and aging of the population as well as advances in early detection and treatment. These treatment disparities are exacerbated by the fact that Black patients continue to be less likely to be diagnosed with stage I disease than White patients for most cancers, with some of the largest disparities for female breast (53% vs 68%) and endometrial (59% vs 73%).

🔑 Key Findings

• To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate triennially to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries, vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics, and population projections from the US Census Bureau.
• Current treatment patterns based on information in the National Cancer Database are presented for the most prevalent cancer types by race, and cancer-related and treatment-related side-effects are also briefly described.
• More than 18 million Americans (8.3 million males and 9.7 million females) with a history of cancer were alive on January 1, 2022.

🔗 Related Resources